Filter
1347
Text search:
COVID
vaccination
Featured
193
16
Language
Document type
385
310
180
149
101
60
41
40
25
22
19
8
7
Countries / Regions
95
49
38
36
33
33
30
30
27
25
23
22
21
20
20
16
15
14
14
14
12
12
11
11
11
10
10
9
9
9
8
8
8
8
8
7
7
7
7
7
7
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
529
58
58
56
55
14
9
2
Toolboxes
776
55
53
33
32
27
26
25
25
24
22
19
16
15
13
10
10
7
7
6
5
5
3
Annex. This document is an update of a guidance published on 12 July 2021, after the review of new scientific evidence on transmission of SARS-CoV-2 variants of concern (VOC). It contains updated recommendations on the use of masks and respirators for health workers providing care to suspected or c
...
Here are resources to help accredited continuing education (CE) providers develop and deliver education about the COVID-19 vaccines. If you have any questions about accreditation requirements or any aspect of accredited education related to these va
...
1 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary include
...
17 February 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
временные рекомендации от 8 января 2021 г.
Available in Arabic, Chinese, English, French, Russian and Spanish here: https://apps.who.int/iris/handle/10665/338484
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants
...
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021
Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
: Déclaration conjointe de l’OMS et de l’UNICEF encourageant une meilleure intégration des produits pharmaceutiques sensibles à la température dans la chaîne d’approvisionnement en produits de santé dans les cas appropriés, 19 novembre 2020
Vacunación frente a la COVID 19: guía de suministro y logística: orientación provisional, 12 febrero de 2021
recommended
12 February 2021
Vacinação contra a COVID-19: orientações relativas ao abastecimento e logística, 12 Fevereiro 2021
recommended
12 February 2021
Cet article fait partie d’une série de notes explicatives sur la mise au point et la distribution de vaccins.
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no
...
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodo
...
